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RHAMNOLIPIDS—BRIEF OUTLINE
Biosurfactants, widely known as surface-
active agents of biological origin, have
carved a niche for themselves in the
market due to their unique environment-
friendly properties. They have come a long
way since first biosurfactant “surfactin”
was purified and characterized by Arima
et al. (1968). Biosurfactants have been
researched thoroughly and satisfacto-
rily since then by many research groups
across the world yet there are aspects
that elude our understanding. There
are five major categories of biosurfac-
tants viz. glycolipids, phospholipids and
fatty acids, lipopeptides and lipoproteins,
polymeric biosurfactants and particulate
biosurfactants that have found appli-
cations in agricultural, pharmaceutical,
food, cosmetics, and detergent indus-
tries. Data reveals there are more than
250 patents obtained on these wonder
biodegradable molecules so far (Shete
et al., 2006; Rahman and Gakpe, 2008). It
has also been observed that microbial bio-
surfactants are advantageous over plant-
based surfactants because of the scale-up
capacity, rapid production, and multi-
functional properties. Several plant-based
biosurfactants for example saponins,
lecithins, and soy proteins have excellent
emulsification properties but are expen-
sive to produce at industrial scale and have
other debatable issues such as solubility
and hydrophobicity (Xu et al., 2011).
Among the various categories of bio-
surfactants the glycolipid biosurfactants
“rhamnolipids” stand apart. Rhamnolipid,
primarily a crystalline acid, is composed of
β-hydroxy fatty acid connected by the car-
boxyl end to a rhamnose sugar molecule.
Rhamnolipids are predominantly pro-
duced by Pseudomonas aeruginosa and
classified as: mono and di-rhamnolipids.
Other Pseudomonas species that have been
reported to produce rhamnolipids are
P. chlororaphis, P. plantarii, P. putida, and
P. fluorescens. Some bacteria are known to
produce only mono-rhamnolipids while
some produce both. The ratio of mono
and di-rhamnolipid can also be controlled
in the production method. There are
enzymes available that can convert mono-
rhamnolipids into di-rhamnolipids. In
1984, the first patent for the production
of rhamnolipids was filed by Kaeppeli and
Guerra-Santos (US 4628030) and obtained
in 1986 for their work on Pseudomonas
aeruginosa DSM 2659 (Kaeppeli and
Guerra-Santos, 1986). Subsequently,
Wagner et al. filed a patent (US 4814272)
in 1985 for the biotechnical production
of rhamnolipids from Pseudomonas sp.
DSM 2874 and obtained the same in 1989
(Wagner et al., 1989). In the past close
to three decades, there has been a great
body of research work carried on rhamno-
lipids revealing many of their astonishing
applications and making them reach the
pinnacle of popularity among all the cat-
egories of biosurfactants in the global
market. The reason behind the current
global interest in rhamnolipid production
owes to their broad range of applications
in various industries along with many
spectacular “eco-friendly” properties.
The current critique articulates to
present opinion on rhamnolipid research
and is an attempt to retrospect what brings
rhamnolipids in the forefront. This arti-
cle is a bird’s-eye view on a timeline
of rhamnolipids story so far and also a
critical analysis on why despite so many
patents and research work rhamnolipids
still do not rule the global biosurfactant
market.
INIMITABLE APPLICATIONS OF
RHAMNOLIPIDS
Over the years rhamnolipids are becom-
ing broadly pertinent in various indus-
tries and are posing a serious threat to
the synthetic surfactants. Before ventur-
ing into the current production economics
of rhamnolipids it is imperative to eval-
uate the major applications of rhamno-
lipids that make them noticeable among
other biosurfactants. A list of five major
applications of rhamnolipids that cater
to the wide range of industrial demands
includes:
(1) Bioremediation and enhanced oil
recovery (EOR): Rhamnolipids show
excellent emulsification properties,
efficiently remove crude oil from
contaminated soil and facilitate biore-
mediation of oil spills (Rahman et al.,
2003; Costa et al., 2010).
(2) Pharmaceuticals and therapeutics:
Rhamnolipids show low toxicity, sur-
face active properties and antimicro-
bial activities against several microbes
(Bacillus cereus, Micrococcus luteus,
Staphylococcus aureus, Listeria mono-
cytogenes) thereby showing promising
applications in pharmaceuticals
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Table 1 | Biosurfactant producing companies around the globe.
S. No. Company Location(s) Product(s) Focus on
1 TeeGene Biotech UK Rhamnolipids and Lipopeptides Pharmaceuticals, cosmetics, antimicrobials
and anti-cancer ingredients
2 AGAE Technologies LLC USA Rhamnolipids (R95, an HPLC/MS
grade rhamnolipid)
Pharmaceutical, cosmeceutical, cosmetics,
personal care, bioremediation (in situ &
ex situ), Enhanced oil recovery (EOR)
3 Jeneil Biosurfactant Co. LLC USA Rhamnolipids (ZONIX, a bio-fungicide
and RECO, a rhamnolipid used in
cleaning and recovering oil from
storage tanks)
Cleaning products, EOR
4 Paradigm Biomedical Inc. USA Rhamnolipids Pharmaceutical applications
5 Rhamnolipid Companies, Inc. USA Rhamnolipids Agriculture, cosmetics, EOR,
bioremediation, food products,
pharmaceutical
6 Fraunhofer IGB Germany Glycolipids, Cellobiose lipids, MELs Cleansing products, shower gels,
shampoos, washing-up liquids,
pharmaceutical (bioactive properties)
7 Cognis Care Chemicals China, Germany, USA Alkyl polyglucoside APG®, Plantacare
1200 GLY (green surfactant for use in
oral-dental formulations), Rheocare
TTA (for cleansing formulations)
Used in formulations for household
cleaners, bath/shower gels, dish washing,
laundry detergents and in agrochemicals
8 Saraya Co. Ltd. Japan Sophorolipids (Sophoron, a low-foam
dishwasher detergent)
Cleaning products, hygiene products
9 Ecover Belgium Belgium Sophorolipids Cleaning products, cosmetics,
bioremediation, pest control,
pharmaceuticals
10 Groupe Soliance France Sophorolipids Cosmetics
11 MG Intobio Co. Ltd. South Korea Sophorolipids
(Sopholine—functional soap with
Sophorolipids secreted by yeasts)
Beauty and personal care, bath supplies
e.g., soaps with new functions
12 Synthezyme LLC USA Sophorolipids Cleaning products, cosmetics, food
products, fungicides, crude oil
emulsification
13 Allied Carbon Solutions (ACS) Ltd Japan Sophorolipids (ACS-Sophor—first
bio-based surfactant from Indian
mahua oil)
Agricultural products, ecological research
14 Henkel Germany Sophorolipids, Rhamnolipids,
Mammoslyerthritol lipids
Glass cleaning products, laundry, beauty
products
15 Lion Corporation Japan Methyl ester sulfonates (MES) Detergents formulations, cleaning products
16 Lipo Chemicals USA Lipomulse Luxe (high-temperature
resistance emulsifier)
Skin care, sun-lotions hair care
formulations, thickening polymers,
rheological modifiers, natural gums
17 Kaneka Co. Japan Sophorose lipids Cosmetics and toiletry products
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and therapeutics (Magalhaes and
Nitschke, 2013).
(3) Cosmetics: Rhamnolipid as an active
ingredient is found to be effective for
several skin treatments i.e., wound
healing with reduced fibrosis, cure
of burn shock, treatment of wrinkles
hence are in demand in the health
and beauty industry (Piljac and Piljac,
2007).
(4) Detergents and cleaners: Rhamnolipids
are natural emulsifiers and surface
active agents leading to their wide
spread usage in detergent composi-
tions, laundry products, shampoos
and soaps (Parry et al., 2013).
(5) Agriculture: Rhamnolipids are already
used for soil remediation for improv-
ing soil quality and are now further
getting explored for plant pathogen
elimination, for aiding the absorption
of fertilizers and nutrients through
roots and as biopesticides (Sachdev
and Cameotra, 2013).
BIOSURFACTANT PRODUCING
COMPANIES—WITH FOCUS ON
RHAMNOLIPIDS
Rhamnolipids are highly applicable in
various activities with some researchers
advancing the technology from laboratory
to higher scale. However, there still are very
limited companies in the field which are
producing biosurfactants at a marketable
scale. We tried to compile a list of bio-
surfactant producing companies around
the globe (Table 1). The compilation evi-
dently defines which biosurfactants are
mostly researched and produced at higher
scale.
AVAILABILITY OF FEEDSTOCK AND ITS
IMPACT ON BIOSURFACTANTS
Biodiesel is produced by the trans-
esterification of vegetable oils and fats
with methanol in the presence of a cata-
lyst. Glycerol is received as a by-product
from this reaction. The production of 1
ton biodiesel generates about 100 kg of
glycerol. Hence, the European biodiesel
industry might release about 600 Kiloton
glycerol per year with an increasing
tendency in Europe and worldwide.
Oversupply of glycerol, essentially due
to increasing biodiesel production, leads
to decreasing prices and weak markets.
The price of pure glycerol varied from
$0.50 to $1.50/lb and crude glycerol from
$0.04/kg to $0.33/kg over the past few
years. The price of glycerol in the mar-
ket will continue to drop in such an
over saturated market. Currently, the main
supply of glycerol coming into the mar-
ket is from the rapidly growing biodiesel
industry. Estimated production of glycerol
would reach 5.8 billion pounds in 2020.
This is due to demand of biodiesel that
is projected at 8 billion gallons in 2020
(Ayoub and Abdullah, 2012). Hence new
outlets for glycerol are urgently needed,
particularly in the case of crude glycerol
released by the biodiesel processes. As glyc-
erol is a nontoxic, edible, biodegradable
compound, it will provide important envi-
ronmental benefits to the new platform
products.
In case of biosurfactant production,
dramatically rising in biodegradable, non-
toxic and eco-friendly alternative for
chemical surfactants and the re-discovered
opportunity of biosurfactants that gave
rise to invention and investment ahead
of the typical rigors of techno-economic
modeling for the use of glycerol as a feed
stock, leading typically to unmet expec-
tations. Bacteria produce biosurfactants if
grown on carbon sources such as glu-
cose, glycerol, and various vegetable oils.
Our research on biosurfactant production
by bacteria indicates that glycerol can be
used efficiently for biosurfactant produc-
tion (Rahman et al., 2002).
The considerable interest in biosurfac-
tants in the recent years is also due to
their low toxicity, biodegradable nature
and specificity, which would be very suit-
able to meet the European Surfactant
Directive. Regulation EC No.: 648/2004
requires clear and precise description of
the biodegradability of the surfactant
and test methods to give assurance of
its aerobic biodegradability. This regula-
tion establishes rules designed to achieve
the free movement of detergents and
surfactants for detergents in the internal
market while, at the same time, ensuring
a high degree of protection of the environ-
ment and human health.
Surfactants constitute an impor-
tant class of industrial chemicals and
are widely used in almost every sec-
tor of modern industry. Most of the
commercially available surfactants are
chemical surfactants mainly, petroleum-
derived. However, rapid advances in
biotechnology and increased environmen-
tal awareness among consumers combined
with expected new environmental legis-
lation has provided further impetus for
serious consideration of biological surfac-
tants as possible alternatives to existing
products.
BIOSURFACTANT’S ECONOMIC
FEASIBILITY—WHAT IT TAKES TO
BECOME A MARKET LEADER?
As described in the previous section,
there is enormous awareness among the
consumers these days with regard to
sustainability and global warming. The
demand for bio-based technologies is
ever increasing and “green solutions” are
sought for every process. Rhamnolipids
have promising properties and fulfill the
eco-friendly criteria, one of the main
Table 2 | Cost of biosurfactant per liter of solution (diluted and the CMC based cost calculation carried out by Connolly et al., 2010).
Biosurfactant Origin Supplier ST mN/m CMC (%) Cost (£/L)
BioFuture Bacterial rhamnolipid BioFuture Ltd. Dublin 28 0.08 0.02
Citrasolv Orange peel Cleveland Biotech Ltd., Teesside 30 0.9 0.01
EC601 Bacterial rhamnolipid Ecochem Ltd., Canada 29 0.2 0.23
EC1800 Bacterial consortium Ecochem Ltd., Canada 28 0.04 0.01
Petrosolv Bacterial unknown Enzyme Technologies Inc., USA 34 0.2 0.01
Saponin Plant bark Sigma UK 45 0.1 0.50
The table also gives the origin of biosurfactant along with surface tension (ST) and critical micelle concentration (CMC) values.
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Table 3 | A timeline and the major patents and grants obtained on rhamnolipids so far.
S. No. Patent or Application No. Filed Issued Title Inventors
1 4628030 Aug 1984 Dec 1986 Process for the production of rhamnolipids Kaeppeli and Guerra-Santos
2 4814272 Feb 1985 March 1989 Process for the biotechnical production of rhamnolipids
including rhamnolipids with only one.
Beta.-hydroxydecanoic acid residue in the molecule
Wagner et al.
3 4933281 March 1987 June 1990 Method for producing rhamnose Daniels et al.
4 4902512 Jan 1988 Feb 1990 Rhamnolipid liposomes Ishigami et al.
5 5417879 Sep 1993 May 1995 Synergistic dual-surfactant detergent composition
containing sophoroselipid
Hall et al.
6 5455232 April 1994 Oct 1995 Pharmaceutical preparation based on rhamnolipid Piljac and Piljac
7 5550227 May 1994 Aug 1996 Method for the preparation of rhamnose monohydrate
from rhamnolipids
Mixich et al.
8 5466675 July 1994 Nov 1995 Immunological activity of rhamnolipids Piljac and Piljac
9 5520839 Jan 1995 May 1996 Laundry detergent composition containing synergistic
combination of sophorose lipid and non-ionic surfactant
Hall et al.
10 5501966 Jan 1995 March 1996 Pseudomonas aeruginosa and its use in a process for
the biotechnological preparation of L-rhamnose
Giani et al.
11 5658793 June 1995 Aug 1997 Pseudomonas aeruginosa and its use in a process for
the biotechnological preparation of L-rhamnose
Giani et al.
12 5514661 Aug 1995 May 1996 Immunological activity of rhamnolipids Piljac and Piljac
13 5767090 Jan 1996 June 1998 Microbially produced rhamnolipids (biosurfactants) for
the control of plant pathogenic zoosporic fungi
Stanghellini et al.
14 7129218 Aug 2000 Oct 2006 Use of rhamnolipids in wound healing, treatment and
prevention of gum disease and periodontal
regeneration
Stipcevic et al.
15 7262171 Aug 2000 Aug 2007 Use of rhamnolipids in wound healing, treating burn
shock, atherosclerosis, organ transplants, depression,
schizophrenia and cosmetics
Piljac and Piljac
16 20040224905 May 2002 Nov 2004 Use of rhamnolipids in wound healing, treatment and
prevention of gum disease and periodontal
regeneration
Stipcevic et al.
17 20060233935 Nov 2003 Oct 2006 Rhamnolipids in bakery products Haesendonck and Vanzeveren
18 7202063 Aug 2005 April 2007 Processes for the production of rhamnolipids Gunther et al.
19 20070191292 Feb 2006 Aug 2007 Antimycotic rhamnolipid compositions and related
methods of use
Gandhi et al.
20 20070155678 Feb 2007 July 2007 Use of rhamnolipids in wound healing, treating burn
shock, atherosclerosis, organ transplants, depression,
schizophrenia and cosmetics
Piljac and Piljac
21 20070207930 Feb 2007 Sep 2007 Rhamnolipid compositions and related methods of use Gandhi et al.
22 7968499 Feb 2007 June 2011 Rhamnolipid compositions and related methods of use Gandhi and Skebba
23 20080213194 July 2007 Sep 2008 Rhamnolipid-based formulations Keith DeSanto
(Continued)
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Table 3 | Continued
S. No. Patent or Application No. Filed Issued Title Inventors
24 7985722 July 2007 July 2011 Rhamnolipid-based formulations Keith DeSanto
25 20100249058 Oct 2007 Sep 2010 Feed additive and feed Ito et al.
26 20090126948 Nov 2007 May 2009 Use of rhamnolipid based formulations for fire
suppression and chemical and biological hazards
Keith DeSanto
27 20080261891 Feb 2008 Oct 2008 Compositions and methods for using syringopeptin
25A and rhamnolipids
Bart C. Weimer
28 20090220603 May 2009 Sep 2009 Use of rhamnolipids in wound healing, treating burn
shock, atherosclerosis, organ transplants, depression,
schizophrenia and cosmetics
Piljac and Piljac
29 20110123623 Nov 2010 May 2011 Rhamnolipid mechanism Keith DeSanto
30 20120322751 Feb 2011 Dec 2012 Use of rhamnolipids as a drug of choice in the case of
nuclear disasters in the treatment of the combination
radiation injuries and illnesses in humans and animals
Goran Piljac
31 20110257115 June 2011 Oct 2011 Method for treating rhinitis and sinusitis by
rhamnolipids
Anton Leighton
32 20110306569 June 2011 Dec 2011 Rhamnolipid biosurfactant from Pseudomonas
aeruginosa strain NY3 and methods of use
Yin et al.
33 8592381 June 2011 Nov 2013 Method for treating rhinitis and sinusitis by
rhamnolipids
Anton Leighton
34 20110270207 July 2011 Nov 2011 Rhamnolipid based formulations Keith DeSanto
35 8183198 July 2011 May 2012 Rhamnolipid-based formulations Keith DeSanto
36 20130130319 July 2011 May 2013 Cells and methods for producing rhamnolipids Schaffer et al.
37 20120255918 April 2012 Oct 2012 Use of rhamnolipids in the water treatment industry DeSanto and Keer
38 20130296461 May 2013 Nov 2013 Aqueous coatings and paints incorporating one or more
antimicrobial biosurfactants and methods for using
same
Lakshmi Sadasivan
39 20130310330 July 2013 Nov 2013 Method for treating obesity Anton Leighton
40 8765694 July 2013 July 2014 Method for treating obesity Anton Leighton
41 20140080771 Nov 2013 March 2014 Method for treating rhinitis and sinusitis by
rhamnolipids
Anton Leighton
42 20140148588 Nov 2013 May 2014 Process for the isolation of rhamnolipids Schilling et al.
drivers, but are still struggling to become
market leaders. The economics of produc-
tion is a major bottleneck in the outburst
of commercialization of rhamnolipids and
other biosurfactants (Table 2). There is
still no downstream technology econom-
ical and convincing enough to recover
and purify rhamnolipids at industrial
scale. In case of biosurfactant production
the downstream processing accounts
for 70–80% of the entire production
costs.
It is a no-brainer that in order to
gain higher profit at commercial scale
it requires access to very cheap feed-
stock. There are some other key parame-
ters that need thorough consideration in
order to make any product economically
feasible. Technological fit and process opti-
mization are among the main drivers.
Fermentation time is another key to suc-
cess. Fermentation performance and scale
impact process economy as it is directly
related to the yield, titer, and produc-
tivity. High cost of production especially
because of the expensive substrates and
down-stream processes makes it difficult
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to bring down the price of these envi-
ronment friendly biomolecules. In order
to compete with the synthetic detergents
or surfactants the cost of production
must be brought down to £1.70 per liter
which is in itself a challenging task. As
there are many barriers in the commer-
cialization of biosurfactants, there seems
no dearth of opportunities in this field.
Cost comparison of various technologies
viz. enzymatic, continuous, shake flask,
batch, and fed-batch used for biosurfac-
tant production pinpoint the requirement
of innovative methods wherein rhamno-
lipids can be produced in static condi-
tions to reduce the fermentation cost. The
operating costs can be brought down by
robust wild-type strains or recombinant
mutant strains. Testing the possibility of
co-products and/or enzymes is another
attractive solution to surge the net profit—
for example: esterases released during the
production of lipopeptides by Bacillus
strain and its recombinants (Sekhon et al.,
2011, 2012). Co-products and by-products
are value drivers and increase the eco-
nomic viability of any business. The search
of cheap and easily accessible raw material
or substrate for biosurfactants production
has been going on for years. The uti-
lization of by-products, even if from a
different process could be another smart
solution—for example: glycerol, which is
a by-product of biodiesel production, is
available in surplus amount in the global
market (Albarelli et al., 2011) which might
be a cheap alternative for biosurfactant
production.
Rhamnolipids are well-characterized
and scientifically proven biosurfactants
which are slowly and steadily becoming
highly sought after biomolecules. Among
other biosurfactants rhamnolipids have
the highest number of patents (Table 3)
and research publications. However, cost-
competitiveness is one of the major
factors that is holding rhamnolipids back
from becoming the champions of their
field. Research needs to be focused on
suitable vigorous production strains,
cheap substrates and nominal bioreac-
tor technology. The current market price
of rhamnolipid (R-95, 95%) is $227/10mg
(Sigma-aldrich) and $200/10mg (AGAE
technologies, USA) calling for strenuous
research. Rhamnolipids have favorable
applications in various sectors and if
made economically sustainable nothing
can stop these biomolecules to rule the
surface-active compounds market.
CONCLUDING REMARKS
As the Health and Safety in the biopro-
cessing become paramount for large scale
production there are significant interests
in the search for novel non-pathogenic
rhamnolipid producers. The numbers of
cultured organisms from the environ-
mental samples are only a tiny fraction
(0.001%) of the actual microbial diversity.
There are significant number of micro-
bial isolates that needs to be explored
and exploited for rhamnolipid and other
bioproduct manufacturing. Biosurfactant
producing probiotic organisms will play
a key role in the future of biosurfac-
tant market. Edible emulsifiers from these
processes would be applicable to many
applications including food, cosmetic,
environmental clean-up, biomedical and
natural therapy. Rhamnolipid could be a
potential alternative for the synthetic sur-
factant molecules and an important plat-
form chemical cluster with the market
value of $2.8 billion in 2023 (Grand View
Research Inc., 2014). There is a signifi-
cant need for the discovery of novel non-
pathogenic rhamnolipid producers with
enhanced production capacity and efforts
to scale up through bioprocess engineering
are important to meet the future predic-
tions of biosurfactants market.
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